MARKER THERAPEUTICS INC (MRKR)
US57055L2060 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.24M | -29.93M | -41.88M | -28.71M | -21.43M | |||
| Depreciation Amortization | N/A | 2.79M | 2.15M | 490.00K | 110.00K | |||
| Change In Working Capital | 2.85M | -5.81M | 5.47M | 2.40M | -2.48M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | -11.05M | 5.98M | 6.98M | 5.79M | 5.52M | |||
| OPERATING CASH FLOW | -16.44M | -26.97M | -27.28M | -20.03M | -18.28M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -4.95M | -3.13M | -9.25M | -370.00K | |||
| Other Investing Activity | 18.66M | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 18.66M | -4.95M | -3.13M | -9.25M | -370.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 1.11M | 200.00K | 52.56M | 6.74M | 820.00K | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 1.11M | 200.00K | 52.56M | 6.74M | 820.00K | |||
| CHANGE IN CASH | 3.33M | -31.72M | 22.15M | -22.54M | -17.83M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.44M | -26.97M | -27.28M | -20.03M | -18.28M | |||
| Capital Expenditure | N/A | -4.95M | -3.13M | -9.25M | -370.00K | |||
| FREE CASH FLOW | -16.44M | -31.92M | -30.41M | -29.28M | -18.65M | |||
All data in USD